While commonly recognized as a pulmonary disease, tuberculosis (TB) is a systemic infection capable of affecting almost any organ in the body. When the Mycobacterium tuberculosis bacteria target the ear structures, it leads to a rare but significant condition known as otic tuberculosis, or tuberculous otitis media. This form of extrapulmonary TB often presents with insidious symptoms, making early diagnosis crucial for preserving ear health.

Symptoms and Diagnostic Challenges

Otic TB can manifest with a range of symptoms that are often mistaken for more common ear infections, leading to delays in appropriate treatment. A hallmark symptom is progressive hearing loss, which can affect one or both ears. This loss may begin subtly but can worsen over time, sometimes accompanied by a persistent, painless ear discharge that does not respond to conventional antibiotics. In advanced cases, the infection can erode the ossicles (the small bones of the middle ear) and even spread to the inner ear.

When the inner ear is involved, patients may experience balance disturbances, manifesting as persistent feelings of unsteadiness, disequilibrium, or true vertigo, commonly referred to as dizziness. Other symptoms might include facial nerve paralysis, tinnitus (ringing in the ears), or localized pain. Diagnosing otic TB is challenging because its presentation mimics other otological conditions. Definitive diagnosis often requires biopsy of ear tissue or culture of ear discharge to identify the Mycobacterium tuberculosis.

Treatment and Outlook

Effective management of otic TB relies on a prompt and accurate diagnosis followed by a comprehensive anti-tuberculous drug regimen. Similar to pulmonary TB, treatment typically involves multiple antimicrobial agents taken over several months to eradicate the bacteria and prevent resistance. The duration and specific drugs used are determined by medical professionals based on established guidelines for treating tuberculosis. Early initiation of treatment is paramount to prevent irreversible damage to the auditory and vestibular systems.

While anti-TB medications are generally effective in clearing the infection, some degree of residual hearing loss or chronic dizziness may persist, especially if the disease was advanced before treatment began. Therefore, awareness of otic TB, particularly in regions where general TB prevalence is high or in individuals with a history of TB exposure, is vital for timely intervention and improving patient outcomes.